John Moroney to Proto-Oncogene Proteins c-akt
This is a "connection" page, showing publications John Moroney has written about Proto-Oncogene Proteins c-akt.
Connection Strength
0.128
-
PIK3CA mutations in patients with advanced cancers treated with PI3K/AKT/mTOR axis inhibitors. Mol Cancer Ther. 2011 Mar; 10(3):558-65.
Score: 0.077
-
An open-label randomized active-controlled phase II clinical study to assess the efficacy and safety of afuresertib plus paclitaxel versus paclitaxel in patients with platinum-resistant ovarian cancer (PROFECTA-II/GOG-3044). Gynecol Oncol. 2025 Mar; 194:145-152.
Score: 0.051